Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- Study type
- Clinical guideline
- Study name
- ATA MTC 2015
- Design
- Evidence-based clinical practice guideline (revision of the original American Thyroid Association guideline) based on a systematic PubMed search
- Source
- Thyroid® · 2015
In plain words
Medullary thyroid cancer is a rare type of thyroid cancer that can occur by chance (sporadic) or be inherited. After a careful review of published studies, the American Thyroid Association wrote 67 recommendations to help doctors diagnose and treat these patients. The details of the right treatment for you depend on your illness and should be discussed with your treating doctor.
Key points
Study population
This guideline focuses on the diagnosis and treatment of patients with sporadic and hereditary medullary thyroid carcinoma (MTC).
Endpoints
The guideline has no clinical endpoint. The task force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC.
Clinical significance and place in guidelines
This revised document updates the original American Thyroid Association guideline and provides 67 evidence-based recommendations for the diagnosis and treatment of sporadic and hereditary MTC. According to the task force, these recommendations represent current, rational and optimal medical practice. The detailed recommendations and the level of evidence for each are not in the abstract and must be taken from the full guideline. The current validity of the guideline and the existence of newer versions should be checked.
Limitations
The abstract describes only the general framework of the guideline and does not include the text of the recommendations or their level of evidence; the detailed recommendations have therefore not been entered on this card and should be added from the full guideline. This guideline was published in 2015 and newer evidence and guidelines may exist.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.